Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Low PD-1 Expression in Cytotoxic CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive ValueGiulia Mazzaschi, Denise Madeddu, Angela Falco, et al.Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.Journal for Immunotherapy of Cancer|November 28, 2023
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)Benedetta Pellegrino, Chiara Tommasi, Olga Serra, et al.International Journal of Molecular Sciences|October 16, 2024
Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1Ilenia Rita Cannizzaro, Mirko Treccani, Antonietta Taiani, et al.Frontiers in Bioscience (Elite Edition)|September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic ScoreGiulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.Immunotherapy|January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinationsMatilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.NPJ Breast Cancer|March 5, 2026
RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancerAlba Llop-Guevara, Benedetta Pellegrino, Isabel Pimentel, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma DatabaseIsabelle Opitz, Andrea Bille, Urania Dafni, et al.Genes|June 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic MechanismsBarbara Moschella, Sabrina Busciglio, Enrico Ambrosini, et al.Pageof 10